Ipsen has reached an agreement to buy fellow French firm ImCheck Therapeutics in a deal that could be worth up to €1 billion ($1.16 billion), adding an antibody-based therapy for acute myeloid ...
Square’s Willem Avé on AI automation, investing in crypto, and what it’s like working for Jack Dorsey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback